Life Insurance After Cancer (Five Years or More Since Treatment)

Why Five Years After Treatment Changes the Picture

An insurer offering life insurance after cancer is pricing one main thing: the chance the cancer comes back or spreads during the policy term. For most cancers that risk is highest in the first few years after treatment and falls as time goes on without a recurrence. That is why insurers usually postpone applications made soon after treatment, and why the same history can look very different on paper once several clear years have passed.

CoverLife works with people whose cancer treatment ended five or more years ago, with no recurrence, who are in remission and either discharged or on routine follow-up. By that stage the application is typically assessed in full rather than deferred, and the conversation moves from "not yet" to "on what terms". Five years is not a magic number for every insurer or every cancer, but it is the point from which we can usually find a sensible route.

If You Are Still in Treatment or Within Five Years

We want to be honest with you rather than take your details and leave you waiting. We are not able to arrange new cover if you are currently having treatment, are waiting for tests, scans or a diagnosis, or finished treatment less than five years ago. Most insurers postpone those applications, and we do not have a route to place them.

The British Insurance Brokers' Association's Find Insurance service (biba.org.uk) can point you to brokers who specialise in cover after a serious illness. If you already hold life cover, keep paying it: a policy taken out before your diagnosis is not affected by it, provided your answers at the time were accurate, and it is worth more than anything you could buy now. And when you reach five years, we would be glad to hear from you.

Ongoing Hormone Therapy Needs a Conversation, Not a Guess

After breast cancer in particular, many people take tamoxifen or an aromatase inhibitor for five years or longer after surgery, chemotherapy or radiotherapy have finished. Some people after prostate cancer have long-term hormone treatment too. This is where the five-year rule needs care.

Insurers usually measure the waiting time from the end of active treatment, as they define it, rather than from your last tablet. But insurers do not all treat ongoing hormone therapy the same way, and the reason you are taking it matters. So if you are on hormone therapy, we will ask about your dates and medication before saying whether we can help, and you must always declare it on the application.

What Insurers Look at, Even Years Later

Time since treatment is the biggest single factor, but it is not the only one. Underwriters build a picture of how likely the cancer was to return in the first place, and whether anything since suggests it might. Expect questions on:

• Type and site: where the cancer started, because cancers behave very differently.
• Stage: how far it had spread, including whether lymph nodes were involved.
• Grade: how abnormal the cells looked, a guide to how aggressive it was.
• Treatment: surgery, chemotherapy, radiotherapy, hormone or targeted therapy, and whether it was curative.
• Date treatment ended: the date the five years runs from.
• Recurrence: any return of the cancer, or any second primary cancer.
• Follow-up: whether you have been discharged or are on routine monitoring, and your latest results.
• Tumour markers where relevant, such as PSA after prostate cancer.

Your wider health counts as it would for anyone: age, smoking, weight, blood pressure and any long-term effects of treatment, such as heart effects from some chemotherapy. With your consent the insurer may ask your GP or consultant for a report, which can add a few weeks.

What Life Insurance Five Years After Cancer Usually Looks Like

Life insurance pays a lump sum if you die during the term. Five or more years after treatment with no recurrence, many insurers will assess the application in full. Some histories, such as early-stage cancers fully treated long ago, are offered standard rates; others carry an increased premium that reflects the type, stage and grade. Level term, decreasing term for a mortgage and whole of life cover are all medically underwritten, so the same questions apply to each.

Income protection is a separate question. It pays a monthly income if illness stops you working, so the insurer also weighs lasting effects of treatment such as fatigue, lymphoedema or neuropathy. A cancer-related exclusion is possible, and your occupation and deferred period shape the terms.

Why a Basal Cell Carcinoma Is Not Treated Like Other Cancers

Not every cancer carries the same weight. Basal cell carcinoma, the most common skin cancer, very rarely spreads, and once fully removed it is usually treated very lightly by insurers. Some application forms ask about it separately from other cancers. Cervical cell changes treated at the pre-cancerous stage are another example of a history insurers tend to view quite differently from invasive cancer.

The contrast runs the other way too. Melanoma is a skin cancer, but it is assessed much more like other invasive cancers, on its depth and stage, and the time since treatment matters a great deal. Whatever the type, the rule is the same: answer exactly what the form asks, and tell us the precise diagnosis from your pathology report rather than a general description. If you also have a family history of cancer, see family history and life insurance.

What to Have Ready Before You Apply

Applications after cancer go better when the facts come from documents rather than memory. Before you contact us or any insurer, gather:

• the date of diagnosis and the date your active treatment ended
• your histology or pathology report, which gives the exact type, stage and grade
• a summary of treatment: operations, chemotherapy, radiotherapy and any hormone or targeted therapy
• your discharge letter, or your most recent follow-up letter if you are still monitored
• any recent tumour marker or scan results, where these are part of your follow-up
• current medication, and any lasting effects of treatment

If you do not have these, your GP surgery or hospital team can usually provide copies. Accurate dates matter most, because the five years runs from when treatment ended.

Always Disclose, However Long Ago It Was

When you apply, the law asks you to take reasonable care to answer the insurer's questions honestly and accurately. Most forms ask whether you have ever had cancer, so a diagnosis from ten or twenty years ago still needs declaring. If it is left out, the insurer may reduce or refuse a claim, or cancel the policy, which is the worst possible outcome for your family. See will life insurance pay out? for more on why this matters.

The reassuring side is that a cancer treated many years ago with no recurrence often makes a modest difference, or none, so honesty usually costs you little.

Why Where You Apply Matters More After Cancer

Insurers do not share an underwriting manual, and cancer is one of the areas where their guidance differs most. For the same cancer, stage and dates, one insurer may offer standard rates, another an increased premium, and a third may still want more time. Applying to them one by one is risky, because later forms ask whether you have ever been declined or postponed.

CoverLife is an FCA-regulated broker working with a panel of 15 UK protection insurers. A named adviser can pre-check your history with insurers whose approach suits it before any full application, at no charge to you. Our broker or direct guide explains the difference.

Support Beyond Insurance

For help with life after cancer, these charities offer information and support: Macmillan Cancer Support, Cancer Research UK, Breast Cancer Now and Prostate Cancer UK.